WW
EW icon

Waterfront Wealth’s Edwards Lifesciences EW Stock Holding History

Waterfront Wealth’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Buy
16,496
+155
+0.9% +$13K 0.24% 122
2026
Q1 		$1.31M Buy
16,341
+887
+6% +$73.1K 0.24% 127
2025
Q4 		$1.3M Buy
15,454
+46
+0.3% +$3.77K 0.25% 121
2025
Q3 		$1.18M Buy
15,408
+7
+0% +$547 0.24% 126
2025
Q2 		$1.2M Sell
15,401
-507
-3% -$37.8K 0.27% 109
2025
Q1 		$1.15M Buy
15,908
+43
+0.3% +$3.08K 0.28% 109
2024
Q4 		$1.17M Buy
15,865
+4,899
+45% +$343K 0.29% 110
2024
Q3 		$776K Buy
+10,966
New +$797K 0.19% 155

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Waterfront Wealth's EW Position: Q2 2026 in Review

Waterfront Wealth increased its Edwards Lifesciences (EW) stake by 0.95% in Q2 2026, buying an estimated $13K and bringing the position to 16,496 shares worth $1.52M. The position accounts for 0.24% of the portfolio, ranked #122.

Waterfront Wealth first reported a position in EW in Q3 2024 and has held it in 8 quarters since. 529 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Waterfront Wealth held 16,496 shares of Edwards Lifesciences worth $1.52M as of Q2 2026.
  • Waterfront Wealth bought 155 Edwards Lifesciences shares in Q2 2026, an estimated $13K.
  • Edwards Lifesciences made up 0.24% of Waterfront Wealth's portfolio in Q2 2026, its #122 holding.
  • Waterfront Wealth first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 8 quarters since.
  • 529 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Waterfront Wealth's 13F filing for Q2 2026, filed 30 Jul 2026.